JPRN-UMIN000015870已完成未知
Phase 2 trial for hematological CR patients of AML after chemotherapy. - Phase 2 trial for hematological CR patients of AML after chemotherapy.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •AML associated with MPD double cancer active infection post hematological stem cell transplantation
研究者
相似试验
进行中（未招募）
1 期
Addition of venetoclax to standard chemotherapy with cytarabine and mitoxantrone in patients with relapsed or refractory acute myeloid leukemia (AML)EUCTR2018-003025-28-DETechnische Universität Dresden54
进行中（未招募）
1 期
Clinical trials for the treatment of acute myeloid leukemia in children and adolescentsMedDRA version: 18.1 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864AMLEUCTR2013-000018-39-ATGesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH gGmbH)625
进行中（未招募）
1 期
Clinical trials for the treatment of acute myeloid leukemia in children and adolescentsAMLMedDRA version: 18.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864EUCTR2013-000018-39-DEGesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH gGmbH)625
进行中（未招募）
3 期
Clinical Trial for the treatment of acute myeloid leukaemia in children and adolescentsC92.0Acute myeloblastic leukaemia [AML]DRKS00022788GPOH gemeinnützige GmbH AML-BFM Studienzentrale164
已完成
不适用
KALL R2 - Acute Lymphoblastic Leukaemia trialAcute Lymphoblastic LeukaemiaCancerISRCTN95257778Medical Research Council (MRC) (UK)200